NUCYNTA®:
Proven efficacy for moderate to
severe acute pain
NUCYNTA, as an opioid, has the risks of addiction, abuse and misuse, which can lead to overdose and death

POWERFUL
EFFICACY



See phase 3 data demonstrating the strength of NUCYNTA for patients with moderate to severe acute pain.

LEARN MORE

CO‑PAY SAVINGS
AVAILABLE FOR ELIGIBLE PATIENTS



Learn about our co‑pay savings offer for your commercially insured patients.

LEARN MORE